Soranib (Sorafenib) 200 mg Company Name: Unnati Pharmax Product Overview Brand Name: Soranib Manufacturer / Company: Unnati Pharmax Active Ingredient: Sorafenib 200 mg Formulation: Film-coated tablet Country of Origin: India Therapeutic Uses Soranib (Sorafenib) is used in the treatment of: Liver cancer (Hepatocellular carcinoma) Advanced kidney cancer (Renal cell carcinoma) Certain types of thyroid cancer Mechanism of Action Sorafenib is an oral multi-kinase inhibitor that slows tumor growth and prevents the development of new blood vessels that feed cancer cells. Dosage & Administration Typical dose: 200 mg tablet, usually taken twice daily (as prescribed). Should be taken on an empty stomach – at least 1 hour before or 2 hours after meals. Side Effects Common side effects may include: Fatigue Nausea, diarrhea, weight loss Rash, skin irritation, hand-foot syndrome Abdominal discomfort Serious but less common side effects include: high blood pressure, bleeding, heart problems, or liver complications. Precautions Pregnancy & Breastfeeding: Not recommended. May cause harm to the unborn baby. Liver Impairment: Dose adjustment may be required. Drug Interactions: Inform your doctor about all other medications. Cardiovascular Risk: Regular monitoring of blood pressure and heart health is advised. Why Choose Unnati Pharmax’s Soranib? Manufactured under strict quality standards Specialized expertise in oncology medicines Trusted by healthcare professionals and patients globally